Minimally invasive versus open total mesorectal excision for rectal cancer: Long-term results from a case-matched study of 633 patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cho M.S. | - |
dc.contributor.author | Kim C.W. | - |
dc.contributor.author | Baek S.J. | - |
dc.contributor.author | Hur H. | - |
dc.contributor.author | Min B.S. | - |
dc.contributor.author | Baik S.H. | - |
dc.contributor.author | Lee K.Y. | - |
dc.contributor.author | Kim N.K. | - |
dc.date.available | 2020-11-02T16:43:42Z | - |
dc.date.issued | 2015-06 | - |
dc.identifier.issn | 0039-6060 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/8512 | - |
dc.description.abstract | Background This study compared the long-term oncologic outcomes of patients with rectal cancer who underwent either laparoscopic or robotic total mesorectal excision (TME) via minimally invasive surgery (MIS) to those patient who underwent open TME. Methods This study was a retrospective, case-control study; patients in the 2 groups were matched according to age, sex, MIS vs open operation, body mass index, tumor location, pathologic TNM stage (ie, tumor-node-metastasis), neoadjuvant treatment, and adjuvant treatment. Results A total of 633 patients (MIS, n = 211; open, n = 422) were assessed. The median follow-up period was 64 (2-124) months. Patient characteristics did not differ between the groups. Overall postoperative complication rates did not differ between the groups (16.0% [MIS]; 17.0% [open]; P = .76). Rates of the involvement of the circumferential resection margin did not differ between the groups (4.0% [MIS]; 5.0% [open]; P = .84). The 5-year overall survival, disease-specific survival, disease-free survival, and local recurrence rates were not different between the MIS and open groups (overall survival = 88.4% vs 85.3%, P = .23; disease-specific survival = 88.8% vs 87.4%, P = .53, disease-free survival = 80.7% vs 78.4%, P = .74; local recurrence = 5.7% vs 5.1%, P = .95). In subgroup analysis, no differences were found in terms of the long-term, oncologic outcomes, oncologic adequacy, and postoperative complications among 3 groups. Conclusion We found no differences in the oncologic outcomes between MIS and open surgery, suggesting that MIS for rectal cancer is a safe option for rectal cancer that does not increase the risk of serious complications. © 2015 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 9 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Mosby Inc. | - |
dc.title | Minimally invasive versus open total mesorectal excision for rectal cancer: Long-term results from a case-matched study of 633 patients | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1016/j.surg.2015.01.010 | - |
dc.identifier.scopusid | 2-s2.0-84929269917 | - |
dc.identifier.wosid | 000354910600018 | - |
dc.identifier.bibliographicCitation | Surgery (United States), v.157, no.6, pp 1121 - 1129 | - |
dc.citation.title | Surgery (United States) | - |
dc.citation.volume | 157 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1121 | - |
dc.citation.endPage | 1129 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | carcinoembryonic antigen | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | anastomosis leakage | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | body mass | - |
dc.subject.keywordPlus | cancer adjuvant therapy | - |
dc.subject.keywordPlus | cancer staging | - |
dc.subject.keywordPlus | cancer surgery | - |
dc.subject.keywordPlus | cancer survival | - |
dc.subject.keywordPlus | case control study | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | disease free survival | - |
dc.subject.keywordPlus | disease specific survival | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | follow up | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | laparoscopic surgery | - |
dc.subject.keywordPlus | long term care | - |
dc.subject.keywordPlus | lymph node metastasis | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | minimally invasive surgery | - |
dc.subject.keywordPlus | open total mesorectal excision | - |
dc.subject.keywordPlus | outcome assessment | - |
dc.subject.keywordPlus | overall survival | - |
dc.subject.keywordPlus | postoperative complication | - |
dc.subject.keywordPlus | postoperative period | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | rectum cancer | - |
dc.subject.keywordPlus | rectum carcinoma | - |
dc.subject.keywordPlus | rectum surgery | - |
dc.subject.keywordPlus | recurrence risk | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | robot assisted surgery | - |
dc.subject.keywordPlus | tumor localization | - |
dc.subject.keywordPlus | tumor recurrence | - |
dc.subject.keywordPlus | tumor volume | - |
dc.subject.keywordPlus | adenocarcinoma | - |
dc.subject.keywordPlus | aged | - |
dc.subject.keywordPlus | colon resection | - |
dc.subject.keywordPlus | comparative study | - |
dc.subject.keywordPlus | evaluation study | - |
dc.subject.keywordPlus | Kaplan Meier method | - |
dc.subject.keywordPlus | minimally invasive surgery | - |
dc.subject.keywordPlus | mortality | - |
dc.subject.keywordPlus | multivariate analysis | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | procedures | - |
dc.subject.keywordPlus | Rectal Neoplasms | - |
dc.subject.keywordPlus | rectoscopy | - |
dc.subject.keywordPlus | risk assessment | - |
dc.subject.keywordPlus | robotic surgical procedure | - |
dc.subject.keywordPlus | South Korea | - |
dc.subject.keywordPlus | survival | - |
dc.subject.keywordPlus | time | - |
dc.subject.keywordPlus | treatment outcome | - |
dc.subject.keywordPlus | Adenocarcinoma | - |
dc.subject.keywordPlus | Aged | - |
dc.subject.keywordPlus | Case-Control Studies | - |
dc.subject.keywordPlus | Colectomy | - |
dc.subject.keywordPlus | Disease-Free Survival | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Follow-Up Studies | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Kaplan-Meier Estimate | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | Minimally Invasive Surgical Procedures | - |
dc.subject.keywordPlus | Multivariate Analysis | - |
dc.subject.keywordPlus | Neoplasm Recurrence, Local | - |
dc.subject.keywordPlus | Proctoscopy | - |
dc.subject.keywordPlus | Rectal Neoplasms | - |
dc.subject.keywordPlus | Republic of Korea | - |
dc.subject.keywordPlus | Retrospective Studies | - |
dc.subject.keywordPlus | Risk Assessment | - |
dc.subject.keywordPlus | Robotic Surgical Procedures | - |
dc.subject.keywordPlus | Survival Analysis | - |
dc.subject.keywordPlus | Time Factors | - |
dc.subject.keywordPlus | Treatment Outcome | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.